Peculiarities of Lipid Metabolism in Patients with Prolactinomas during Suppressive Dopamine Agonist Therapy
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 4, Issue 68
Abstract
The article presents the data of lipid metabolism at the stages of long-term (12 months) suppressive therapy with dopamine agonist cabergoline in 61 patients with prolactinoma. It is proved that the normalization of prolactin levels during therapy reduces the risk of development and progression of atherogenesis through reduction of total cholesterol content and increase in high-density lipoprotein cholesterol. Suppressive pharmacotherapy with cabergoline reduces the total cholesterol level in both men and women. Men had most pronounced improvement in the ratio of pro- and antiatherogenic lipid fractions.
Authors and Affiliations
T. H. Hohitidze
Keywords
Related Articles
- EP ID EP222297
- DOI -
- Views 52
- Downloads 0
Development of Organizational Technologies for harmaceutical Care to Outpatients (on the Example of Diabetes Mellitus)
Taking into account global trends in the development of healthcare, there were scientifically grounded conceptual model of pharmaceutical care to outpatients with diabetes mellitus and the integrated technology of managi...
Hyperparathyroidism: Diagnosis, Clinical Signs and Symptoms, Modern Approaches to Treatment
.
Dynamics of Hormonal and Immunological Indexes during Conservative Treatment of Patients with Diffuse Toxic Goiter
The dynamics of structural and functional state of thyroid gland was studied, as well as the levels of antithyroid antibodies in patients with diffuse toxic goiter (DTG) during long-term treatment with thyrostatic agents...
Parameters of stimulation electroneuromyography in patients with primary hypothyroidism
Background. The purpose of the work is to identify the parameters of stimulation electroneuromyography (ENMG) in patients with primary hypothyroidism against the background of autoimmune thyroiditis and postoperative hyp...
Influence of recombinant human thyroid-stimulating hormone of and radioiodine therapy on the function of cells of innate immunity in patients with thyroid cancer
Background. The effect of radioiodine therapy (RIT) on the cytotoxic activity of NK cells and the metabolic activity of neutrophils (NF) in patients with differentiated thyroid cancer (DTC) was studied on the background...